<div id="readability-page-1"><div>NEW YORK CITY, NY / ACCESS Newswire / December 12, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Baxter International, Inc. (&#34;Baxter&#34; or the &#34;Company&#34;) . Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns whether Baxter and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.You have until December 15, 2025, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Baxter securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.[Click here for information about joining the class action]On July 31, 2025, Baxter announced that it had decided to &#34;voluntarily and temporarily pause shipments and planned installations of the Novum LVP&#34;, a medical device used for the controlled delivery of intravenous fluids, and that the Company was &#34;unable to currently commit to an exact timing for resuming shipment and installation for Novum IQ LVPs.&#34; Baxter stated that they had offered &#34;customers the option of our Spectrum infusion pump as an alternative&#34; and that the Company's low-end guidance assumes that the Company does not resume shipments for Novum LVPs before the end of the year.On this news, Baxter's stock price fell $6.29 per share, or 22.4%, to close at $21.76 per share on July 31, 2025.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.Attorney advertising. Prior results do not guarantee similar outcomes.SOURCE: Pomerantz LLPView the original press release on ACCESS Newswire</div></div>

Pomerantz LLP has filed a class action lawsuit against Baxter International, Inc. for alleged securities fraud. Investors are advised to contact Danielle Peyton for joining the class action. Baxter's stock fell 22.4% after announcing a pause in shipments of Novum LVP medical devices. The deadline to appoint a Lead Plaintiff is December 15, 2025.

Pomerantz LLP Notifies Investors of Class Action Filing Against Baxter International, Inc. – BAX